Optimed Medizinische Instrumente GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Optimed Medizinische Instrumente GmbH - overview
Established
1995
Location
-, -, Germany
Primary Industry
Medical Devices & Equipment
About
Optimed Medizinische Instrumente GmbH develops and manufactures advanced medical devices for minimally invasive therapies, focusing on high-quality products such as PTA balloons and vascular stents to enhance patient outcomes. Founded in 1995 in Germany, Optimed Medizinische Instrumente GmbH is dedicated to the research and manufacturing of medical instruments. The company operates without known subsidiaries or major strategic pivots. The current leadership team includes CEOs Guido Derjung, Jürgen Kiesel, Stefan Gimber, and Szewczyk Piotr.
Optimed specializes in the research, development, manufacturing, and distribution of high-quality medical products specifically designed for minimally invasive therapy. Their core product offerings include semi-compliant PTA balloons and flexible open-cell stents tailored for vascular applications, especially in small vessels and the superficial femoral artery. The company serves a diverse clientele, including hospitals and medical facilities across Europe, Argentina, Australia, and the Middle East, aiming to provide crucial medical solutions such as ductus stents for pediatric patients. In 2022, Optimed generated revenue of USD 25.
28 mn, with an EBITDA of USD 1. 11 mn. The company primarily engages in B2B transactions, supplying medical devices directly to healthcare providers, which allows for streamlined procurement and builds long-term relationships with hospitals. Their advanced stents and PTA balloons are essential in various medical specialties, with pricing determined by product complexity and market demand.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.opti-med.de
Total Amount Raised
Subscriber access only
Optimed Medizinische Instrumente GmbH - timeline of key events
Optimed Medizinische Instrumente GmbH - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | 12,492,728.4 | 26,343,808.2 | 23,992,050.8 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | 110.9% | (8.9%) | - | - | - |
| EBITDA (USD) | 3,641,980.5 | 4,052,907.3 | 4,467,744.2 | 2,612,706.9 | 3,632,664.4 | 3,367,578.3 | 2,657,786.2 | 1,251,416.4 | 1,603,604 | 1,147,630.4 | - | - | - |
| Operating Income (USD) | 3,384,619.1 | 3,782,660.5 | 4,183,885.7 | 2,302,191.1 | 3,340,641.8 | 3,105,901.1 | 2,408,539.8 | 1,124,469.7 | 1,202,037.7 | 769,916.2 | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | 9.0% | 4.6% | 3.2% | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | 10.0% | 6.1% | 4.8% | - | - | - |
| NET Income (USD) | 3,348,787.3 | 2,722,622.7 | 3,030,849.1 | 1,676,075.6 | 2,441,596.1 | 2,282,096.3 | 1,637,587.3 | 817,122.1 | 1,215,917.2 | 798,109.1 | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | 6.5% | 4.6% | 3.3% | - | - | - |
Optimed Medizinische Instrumente GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | E Med Solutions GmbH | - |
Displaying 1 - 1 of 1
Optimed Medizinische Instrumente GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.